5 Best Single Digit Stocks to Buy Now

4. Amneal Pharmaceuticals, Inc. (NYSE:AMRX)

Number of Hedge Fund Holders: 17

Amneal Pharmaceuticals, Inc. (NYSE:AMRX) is an integrated pharmaceutical company that manufactures and markets complex oral solids, injectables, soft gels, and inhalation products. Amneal Pharmaceuticals, Inc. (NYSE:AMRX) ranks fourth on our list of the best single digit stocks to buy now.

In August, Piper Sandler lifted its price target on Amneal Pharmaceuticals, Inc. (NYSE:AMRX) to $9.00, while maintaining its ‘Overweight’ rating on the shares. The firm noted the efficacy of the company’s IPX-203 capsule in a late-stage trial in a group of patients with Parkinson’s disease. In Q2 2021, Amneal Pharmaceuticals, Inc. (NYSE:AMRX) posted an EPS of $0.25, beating the consensus by $0.06. The consolidated revenue presented a 15.2% growth from the prior-year quarter at $535.07 million. In the past year, Amneal Pharmaceuticals, Inc. (NYSE:AMRX) delivered a 39.8% return to shareholders.

As of Q2 2021, 17 hedge funds tracked by Insider Monkey have positions in Amneal Pharmaceuticals, Inc. (NYSE:AMRX), up from 15 in the previous quarter. The total value of these stakes is $53.6 million.